TARP is an immunotherapeutic target in acute myeloid
- Slides: 6
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment by Barbara Depreter, Karin E. Weening, Karl Vandepoele, Magnus Essand, Barbara De Moerloose, Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors, Inge D’hont, Barbara Denys, Anne Uyttebroeck, An Van Damme, Laurence Dedeken, Sylvia Snauwaert, Glenn Goetgeluk, Stijn De Munter, Tessa Kerre, Bart Vandekerckhove, Tim Lammens, and Jan Philippé haematol Volume 105(5): 1306 -1316 May 1, 2020 © 2020 by Ferrata Storti Foundation
Characteristics of de novo acute myeloid leukemia (AML) patients used for sorting CD 34+CD 38+ and CD 34+CD 38− cell fractions and qualitative polymerase chain reaction evaluation. Barbara Depreter et al. Haematologica 2020; 105: 1306 -1316 © 2020 by Ferrata Storti Foundation
T-cell receptor γ chain alternate reading frame protein (TARP) transcript expression in pediatric acute myeloid leukemia (ped. AML) and adult AML leukemic cells and cell lines. Barbara Depreter et al. Haematologica 2020; 105: 1306 -1316 © 2020 by Ferrata Storti Foundation
T-cell receptor γ chain alternate reading frame protein (TARP) expression in cell lines evaluated by western blotting. Barbara Depreter et al. Haematologica 2020; 105: 1306 -1316 © 2020 by Ferrata Storti Foundation
T-cell receptor γ chain alternate reading frame protein (TARP) protein detection in Kg-1 a and patient leukemic cells by confocal microscopy. Barbara Depreter et al. Haematologica 2020; 105: 1306 -1316 © 2020 by Ferrata Storti Foundation
Functional evaluation of T-cell receptor (TCR)-transgenic cytotoxic T cells (CTL) towards cognate and modified cell lines and patient leukemic cells. Barbara Depreter et al. Haematologica 2020; 105: 1306 -1316 © 2020 by Ferrata Storti Foundation
